However, compared to the Model group, the TAC-treated group showed a significant increase in ZO-1 and occludin1 protein expression, indicating that TAC is associated with the protective effect of the gut mucosal barrier. This evidence concerns the gene TJP1 and persistent truncus arteriosus.